Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Fortress Biotech (FBIO) EPS (Weighted Average and Diluted) (2018 - 2025)

Fortress Biotech (FBIO) has 8 years of EPS (Weighted Average and Diluted) data on record, last reported at $0.12 in Q3 2025.

  • For Q3 2025, EPS (Weighted Average and Diluted) rose 115.79% year-over-year to $0.12; the TTM value through Sep 2025 reached -$0.12, up 96.08%, while the annual FY2024 figure was -$2.69, 68.24% up from the prior year.
  • EPS (Weighted Average and Diluted) reached $0.12 in Q3 2025 per FBIO's latest filing, down from $0.5 in the prior quarter.
  • Across five years, EPS (Weighted Average and Diluted) topped out at $0.5 in Q2 2025 and bottomed at -$15.29 in Q4 2022.
  • Average EPS (Weighted Average and Diluted) over 5 years is -$1.67, with a median of -$0.38 recorded in 2021.
  • Peak YoY movement for EPS (Weighted Average and Diluted): crashed 3923.68% in 2022, then surged 168.49% in 2025.
  • A 5-year view of EPS (Weighted Average and Diluted) shows it stood at -$0.38 in 2021, then tumbled by 3923.68% to -$15.29 in 2022, then skyrocketed by 96.53% to -$0.53 in 2023, then skyrocketed by 50.94% to -$0.26 in 2024, then surged by 146.15% to $0.12 in 2025.
  • Per Business Quant database, its latest 3 readings for EPS (Weighted Average and Diluted) were $0.12 in Q3 2025, $0.5 in Q2 2025, and -$0.48 in Q1 2025.